Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Infliximab Improves Psoriatic Nail Disease
Link ID 3482
Title Infliximab Improves Psoriatic Nail Disease
Url http://www.medscape.com/viewarticle/570563?src=rss
Description Infliximab is highly effective for treatment of psoriatic nail disease, according to a post-hoc analysis of the European Infliximab for Psoriasis (Remicade) Efficacy and Safety Study. Reuters Health Information
Category Articles > Dermatology
Keywords
Date Feb 23, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Dermatology
1. Sudden Onset of Verrucous Plaques to the Face and Trunk: A Case of Reactivation Cutaneous Histoplasm
  This case emphasizes the importance of increasing awareness of histoplasmosis in nonendemic areas as a result of the large subgroup of immunocompromised patients at risk.
Dermatology Online Journal
Category:   Articles > Dermatology


2. Novel Biologic Agent Proves Highly Effective in Severe Plaque Psoriasis
  In PHOENIX 1, a multicenter, double-blind, randomized, placebo-controlled trial, ustekinumab showed long-term, sustained efficacy in the treatment of plaque psoriasis. Medscape Medical News
Category:   Articles > Dermatology


3. Quinapril Fails to Prevent Vascular Damage in Scleroderma
  The long-acting angiotensin-converting enzyme (ACE) inhibitor quinapril does not appear to prevent upper limb digital ulcers or other vascular manifestations in patients with limited cutaneous systemic sclerosis (lcSSc), according to UK researchers. Reuters Health Information
Category:   Articles > Dermatology


4. Endometriosis Linked to Increased Risk for Melanoma
  A large French cohort study provides the strongest evidence thus far of a positive association between a history of endometriosis and melanoma risk, as well as an association with fibroma. Medscape Medical News
Category:   Articles > Dermatology


5. FDA Safety Changes: Cipro, Herceptin, Antimicrobial and Monolactam Antibiotics
  The FDA has approved revisions to the safety labeling for ciprofloxacin, trastuzumab intravenous infusion, erythromycin, and aztreonam injection for intravenous use. Medscape Medical News
Category:   Articles > Dermatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS